| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802234301018 | 223430101 | TRINIPATCH TTS 5MG/24HRS ΒΤ x 30 ΤΕ x 7 cm2 (IN SACH) | 7.45 | 7.81 | 10.76 |
| 05/2018 | 2802234302015 | 223430201 | TRINIPATCH TTS 10MG/24HRS BT x 30 ΤΕ x 14 cm2 (IN SACH) | 9.46 | 9.92 | 13.67 |
For the prevention of angina
Similar to other nitrites and organic nitrates, nitroglycerin is converted to nitric oxide (NO), an active intermediate compound which activates the enzyme guanylate cyclase. This stimulates the synthesis of cyclic guanosine 3',5'-monophosphate (cGMP) which then activates a series of protein kinase-dependent phosphorylations in the smooth muscle cells, eventually resulting in the dephosphorylation of the myosin light chain of the smooth muscle fiber. The subsequent release of calcium ions results in the relaxation of the smooth muscle cells and vasodilation.
Increased intracranial pressure, with any or all of persistent throbbing headache, confusion, and moderate fever; Vertigo; Palpitations; Visual disturbances; Nausea and vomiting (possibly with colic and even bloody diarrhea); Syncope (especially in the upright posture); Air hunger and dyspnea, later followed by reduced ventilatory effort; Diaphoresis, with the skin either flushed or cold and clammy; Heart block and bradycardia; Paralysis; Coma; Seizures; Death.
3 minutes
* 3 L/kg
* 1 L/kg/min